Sarepta Therapeutics, Inc. (SRPT)

21.14 -2.69 (-11.29%) USD  |  NASDAQ  |  Jan 12, 16:00
21.34 +0.20 (+0.95%) Pre-Market: 07:58
More

Sarepta Therapeutics Normalized Basic EPS (Quarterly)

Normalized Basic EPS (Quarterly) Chart

View Normalized Basic EPS (Quarterly) for SRPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Normalized Basic EPS (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Normalized Basic EPS (Quarterly) Range, Past 5 Years

View Normalized Basic EPS (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Normalized Basic EPS (Quarterly) Benchmarks

View Normalized Basic EPS (Quarterly) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Amgen, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade